type here...

CATEGORIES

Clinical Trials

LATEST

123Page 1 of 3

TRENDING

EDITORS CHOICE

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

Dallas researchers aim to accelerate women’s health clinical trials

Cedar Health Research -
Local Dallas Fort Worth researchers are combining critical components that can help accelerate research for women’s health trials

This Is Why We Should NEVER Rush A Vaccine To Market

Dr. Hesham A. Hassaballa -
We need a vaccine for Covid-19. It is a matter of life and death. At the same time, that vaccine has to be proven to be safe and effective

Tech Marches On, While Humanity Drags Its Feet

John Nosta -
I thought it would be fun to look back at some of my predictions for health tech from almost a decade ago in Forbes....

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories